[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366870-105":59,"doc-detail-366870-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","turmeric-extracellular-vesicles-derived-all-in-one-nanoagent-enables-full-cycle-synergistic-immunomodulation-of-lung-cancer","Turmeric extracellular vesicles-derived “all-in-one” nanoagent enables full-cycle synergistic immunomodulation of lung cancer","","Lung cancer’s high metastatic and recurrence rates require immunotherapy beyond single-mode regulation. A study engineered low-capacity turmeric-derived extracellular vesicles (TEVs) integrated with ZIF-8 to create an “all-in-one” nanoagent addressing high drug-loading production and immunologically cold tumors. The system co-delivers chlorin e6 (Ce6) and PD-L1 siRNA and uses TEVs’ curcumin to inhibit the Wnt/β-catenin pathway. Ce6-PDT triggers immunogenic cell death (ICD), releasing DAMPs to activate antigen-presenting cells and promote immune infiltration, while PD-L1 siRNA reduces checkpoint expression and prevents immune escape. In vivo results show strong primary tumor suppression and metastasis reduction, with improved payload loading efficiency compared with liposomal carriers. The platform enables full-cycle immune coordination to convert immunosuppressive tumors into immunotherapy-responsive targets.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/turmeric-extracellular-vesicles-derived-all-in-one-nanoagent-enables-full-cycle-synergistic-immunomodulation-of-lung-cancer/366870/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/turmeric-extracellular-vesicles-derived-all-in-one-nanoagent-enables-full-cycle-synergistic-immunomodulation-of-lung-cancer/366870.png","ImageObject",300,407,{"name":92,"@type":93},"OmBimo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does the system achieve full-cycle synergistic immunomodulation?","Question",{"text":112,"@type":113},"It co-delivers Ce6 and PD-L1 siRNA, triggers ICD to release DAMPs and activate antigen-presenting cells, inhibits the Wnt/β-catenin pathway to enhance T cell infiltration, and reduces PD-L1 expression to limit immune escape.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What outcomes were reported in vivo?",{"text":117,"@type":113},"The approach achieved strong primary tumor suppression and reduced metastasis compared with monotherapy groups, alongside higher payload loading efficiency than liposomal carriers.",{"name":119,"@type":110,"acceptedAnswer":120},"Why target “cold” tumors in this work?",{"text":121,"@type":113},"The study addresses immunologically cold tumor microenvironments and low immunogenicity, which often lead to suboptimal immunotherapy results in high-burden solid tumors.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},366870,1790780769,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},962090893581,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Bioactive Materials 56 (2026) 666–681  \nContents lists available at ScienceDirect  \nBioactive Materials  \njournal [homepage:](homepage: www.keaipublishing.com/en/journals/bioactive-materials)[ www.keaipublishing.com/en/journals/bioactive-materials](homepage: www.keaipublishing.com/en/journals/bioactive-materials)  \n| Turmeric extracellular vesicles-derived “all-in-one” nanoagent enables full-cycle synergistic immunomodulation of lung cancer |  |  | |\n| --- | --- | --- | --- |\n| Jichun Yanga,b,*,1 , Qianqian Wu b,e,1, Yunqian Fub,1, Xiaohui Chen b, Hengyi Chen b, Yuhan Wang b, Xiang Wu d, Xin Cuib, Sitong Wang b, Yao Luob, Yufang Zhang b, Yican Lib, Yan Zhao b, Zhixin Chab,e, Linke Shi b, Xianlong Jiao d,**, Fang Li c,***,\u003Cbr>Yang Luo a,b,e,****\u003Cbr>a Department of Laboratory Medicine, Chongqing General Hospital, School of Medicine, Chongqing University, Chongqing, 401147, PR China b Center of Smart Laboratory and Molecular Medicine, School of Medicine, Chongqing University, Chongqing, 400044, PR China c Department of Ultrasound, Chongqing University Cancer Hospital, School of Medicine, Chongqing University, Chongqing, 400030, PR China d College of Computer Science, Chongqing University, Chongqing, 401331, PR China\u003Cbr>e College of Life Science and Laboratory Medicine, Kunming Medical University, Kunming, Yunnan, 650500, PR China |  |  |  |\n| A R T I C L E I N F O |  | A B S T R A C T |  |\n| Keywords:\u003Cbr>Lung cancer\u003Cbr>Immunotherapy\u003Cbr>Plants-derived extracellular vesicles Full-cycle immunomodulation |  | Lung cancer’s metastatic propensity and recurrence prevalence necessitate innovative immunotherapy strategies beyond conventional single-mode regulation. We engineered low-capacity turmeric-derived extracellular vesicles (TEVs) that integrated with zeolitic imidazolate framework-8 (ZIF-8) to construct an “all-in-one” nanoagent, addressing both high drug loading nanocarriers production and immunologically cold tumor challenges. The system co-delivered chlorin e6 (Ce6) and PD-L1 siRNA, while exploited TEVs’ inherent curcumin for Wnt/β-catenin pathway inhibition. Ce6-mediated photodynamic therapy (PDT) induced immunogenic cell death (ICD), releasing damage associated molecular patterns (DAMPs) to activate antigen-presenting cells (APCs). Compared with control groups, artificial intelligence model confirmed the role of curcumin in enhancing immune infiltration by 6.1-fold. PD-L1 siRNA synergistically downregulates the checkpoint expression with a 66 % reduction in vivo to prevent the immune escape. This coordinated strategy achieved full-cycle immunomodulation: (1) ICD initiated antigens release,(2) Wnt/β-catenin pathway inhibition drived T cell infiltration, and (3) PD-L1 blockade receded the immune escape. In vivo results demonstrated that 64 % primary tumor suppression and 81 % metastasis reduction versus monotherapy groups. The ZIF-8@TEV hybrid platform exhibited 12.8 % payload loading efficiency, surpassing liposomal carriers by 4.7-fold. This study established a scalable nanoengineering approach to transform immunosuppressive tumors into immunotherapy-responsive targets through a full-cycle immune coordination. |  |\n\n1. Introduction  \nLung cancer is the most common cancer in the world today, in terms of both incidence and mortality [1–3]. Surgical resection, radiotherapy  \nand chemotherapy as conventional treatments in clinic achieve certain therapeutic effect, while fail to prevent the metastasis and recurrence of lung cancer [4,5]. Recently, immunotherapy has emerged as a promising strategy for lung cancer therapy by activating the patient’s immune  \nPeer review under the responsibility of editorial board of Bioactive Materials.  \n* Corresponding authors. Department of Laboratory Medicine, Chongqing General Hospital, School of Medicine, Chongqing University, Chongqing, 401147, PR China.  \n** Corresponding author. College of Computer Science, Chongqing University, Chongqing, 401331, PR China.  \n*** Corresponding authors. Depa","cbCaidd14ikEWMrb","https://ap.wps.com/l/cbCaidd14ikEWMrb","pdf",17520847,16,"English","# Introduction\n## Conventional therapies and limitations\n## Immunotherapy prospects and challenges\n## Strategies combining ICD with checkpoint modulation","[{\"question\":\"How does the system achieve full-cycle synergistic immunomodulation?\",\"answer\":\"It co-delivers Ce6 and PD-L1 siRNA, triggers ICD to release DAMPs and activate antigen-presenting cells, inhibits the Wnt/β-catenin pathway to enhance T cell infiltration, and reduces PD-L1 expression to limit immune escape.\"},{\"question\":\"What outcomes were reported in vivo?\",\"answer\":\"The approach achieved strong primary tumor suppression and reduced metastasis compared with monotherapy groups, alongside higher payload loading efficiency than liposomal carriers.\"},{\"question\":\"Why target “cold” tumors in this work?\",\"answer\":\"The study addresses immunologically cold tumor microenvironments and low immunogenicity, which often lead to suboptimal immunotherapy results in high-burden solid tumors.\"}]","Turmeric extracellular vesicles-derived “all-in-one” nanoagent enables full-cycle synergistic immunomodulation of lung cancer | PDF",1790168044,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/49f71dec54ee0d30f4fb8a5ae23a1ced.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/235727679876595802d2726f29b0be3d.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f68607945d83eb66183cacdb64788321.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ec7e805517eb0d269d26d7721cda078e.webp",980,1306]